Business Services Industry

Asterand plc Board Appointment

Business Wire, Sept 2, 2008

DETROIT -- Asterand plc (LSE: ATD), a leading provider of human tissue and services to pharmaceutical companies engaged in drug discovery research, announces the appointment of Jonathan J. Fleming as a Non-Executive Director. Mr. Fleming is currently the Managing Partner of Oxford Bioscience Partners (Boston, MA). In addition, the Company discloses that David A. Jones, Jr., has stepped down from the Board. All changes are with immediate effect.

Since 1996 Mr. Fleming has been a General Partner of Oxford Bioscience Partners and currently serves as the Managing General Partner. Oxford Bioscience Partners is an international venture capital firm with more than $ 900 million under management that specializes in life science technology based investments. Oxford Bioscience Partners is a major shareholder of Asterand plc and is the founding Venture firm of its predecessor company, Asterand Inc. Mr. Fleming holds a BA from the University of California, Berkeley and a MPA from Princeton University. Mr. Fleming currently serves as Director of several private companies and is the Chairman of the Board of Memory Pharmaceuticals Corp. (Nasdaq: MEMY). Mr. Fleming is presently a Director of Leerink Swann Investment Trust (Boston, MA), an investment bank specializing in life sciences.

Jack Davis, Chairman of Asterand plc commented:

"I'm pleased to welcome Jonathan to the Board. He is an accomplished business leader with a proven track record of using his expertise to maximise the value of high growth companies. As we converge on our strategic objectives of sustained profitability and future growth, I am confident that his experience in the life science and healthcare sectors will be invaluable.

I'd also like to take this opportunity to thank David Jones for his service to the Company. He is Chairman and Managing Director of Chrysalis Ventures, a major shareholder of Asterand, and has served as a Board member of Asterand, Inc. and then subsequently Asterand plc since 2003. David has been an outstanding Director and we are grateful for the assistance he has provided in bringing Asterand to this key stage in its development. We look forward to his and Chrysalis Ventures' continued support in the future."

About Asterand:

www.asterand.com

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale